Characterization of long-term survival in Medicare patients undergoing arteriovenous hemodialysis access
Journal of Vascular Surgery · 2024-04 · 79 (4) · 925-930
DOI: 10.1016/j.jvs.2023.12.031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Vascular Surgery, 2024-04. Verfasst von Matthew R Smeds und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, St. Louis University, St. Louis, MO. Hauptthemen laut MEDLINE: Arteriovenous Shunt, Surgical, Fistula, Kidney Failure, Chronic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: FDA HHS, Boston University, U.S. Food and Drug Administration.
Abstract (Originalsprache)
BACKGROUND: Patients undergoing arteriovenous (AV) access creation for hemodialysis often have significant comorbidities. Our goal was to quantify the long-term survival and associated risks factors for long-term mortality in these patients to aid in optimization of goals and expectations. METHODS: The Vascular Implant Surveillance and Interventional Outcomes Network Vascular Quality Initiative Medicare linked data was used to assess long-term survival in the HD registry. Demographics, comorbidities, and interventions were recorded. Because the majority of hemodialysis patients are provided Medicare, Medicare linkage was used to obtain survival data. Multivariable analysis was used to identify independent associations with mortality. RESULTS: There were 13,945 AV access patients analyzed including 10,872 (78%) AV fistulas and 3073 (22%) AV grafts. The median age was 67 years and 56% of patients were male. Approximately one-third had a prior AV access and 44.7% had prior tunneled dialysis catheters. Patients receiving an AV fistula, compared with AV grafts, were more often younger, male, White, obese, independently ambulatory, preoperatively living at home, and less often have a prior AV access and tunneled dialysis catheters (P < .05 for all). The 5-year mortality overall was 62.9% with 61.2% for AV fistulas and 68.8% for AV grafts (P < .001). On multivariable analysis for 5 year mortality, nonambulatory status (hazard ratio [HR], 1.67; 95% confidence interval [CI], 1.53-1.83; P < .001), lower extremity access (HR, 1.67; 95% CI, 1.35-2.05; P < .001), human immunodeficiency virus or acquired immunodeficiency syndrome (HR, 1.44; 95% CI, 1.13-1.82; P < .001), White race (HR, 1.43; 95% CI, 1.35-1.51; P < .001), congestive heart failure (HR, 1.33; 95% CI, 1.26-1.41; P < .001), chronic obstructive pulmonary disease (HR, 1.23; 95% CI, 1.15-1.31; P < .001), and AV graft placement (HR, 1.12; 95% CI, 1.02-1.23, P = .016) were most associated with poor survival. Factors associated with improved survival were never smoking (HR, .73; 95% CI, 0.67-0.79; P < .001), prior/quit smoking (HR, .78; 95% CI, 0.72-0.84; P < .001), preoperative home living (HR, .75; 95% CI, 0.68-0.83; P < .001), and hypertension (HR, .89; 95% CI, 0.8-0.99; P = .03). CONCLUSIONS: Long-term survival in Medicare patients undergoing AV access creation is poor with nearly two-thirds of patients having died at 5 years. There are many modifiable risk factors that may improve survival in these patients and give an opportunity for transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Vascular and Endovascular Surgery, St. Louis University, St. Louis, MO.
- Division of Vascular and Endovascular Surgery, Chobanian and Avedisian School of Medicine, Boston University, Boston, MA; Division of Vascular and Endovascular Surgery, Dartmouth Medical School, Lebanon, NH.
- Division of Vascular and Endovascular Surgery, Chobanian and Avedisian School of Medicine, Boston University, Boston, MA.
- Division of Vascular and Endovascular Surgery, Dartmouth Medical School, Lebanon, NH.
- Division of Vascular and Endovascular Surgery, Chobanian and Avedisian School of Medicine, Boston University, Boston, MA. Electronic address: Jeffrey.Siracuse@bmc.org.
Förderung
- FDA HHS
- Boston University
- U.S. Food and Drug Administration
Zitieren
APA
Smeds, M. R., Cheng, T. W., King, E., Williams, M., Farber, A., Chitalia, V. C., Siracuse, J. J., & VQI VISION (2024). Characterization of long-term survival in Medicare patients undergoing arteriovenous hemodialysis access. Journal of Vascular Surgery, 79(4), 925-930. https://doi.org/10.1016/j.jvs.2023.12.031
Vancouver
Smeds MR, Cheng TW, King E, Williams M, Farber A, Chitalia VC, et al. Characterization of long-term survival in Medicare patients undergoing arteriovenous hemodialysis access. Journal of Vascular Surgery. 2024;79(4):925-930. doi:10.1016/j.jvs.2023.12.031
BibTeX
@article{Smeds2024,
author = {Smeds, Matthew R and Cheng, Thomas W and King, Elizabeth and Williams, Michael and Farber, Alik and Chitalia, Vipul C and Siracuse, Jeffrey J and VQI VISION, VQI VISION},
title = {Characterization of long-term survival in Medicare patients undergoing arteriovenous hemodialysis access},
journal = {Journal of Vascular Surgery},
year = {2024},
volume = {79},
number = {4},
pages = {925--930},
doi = {10.1016/j.jvs.2023.12.031}
}
EUVIMED